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Abstract
Background: Pancreatic cancer (PC) is as the twelfth most frequent cancer and 
the seventh most important cause of mortality by reason of cancer in the world. 
Being informed about the incidence and mortality of this cancer and the 
potential role of development is useful in health policy. The aim of this research 
is investigating disparities in the incidence and mortality of PC in the world 
countries in the year 2012. Methods: This study was an ecologic study in the 
World for assessing the correlation between Human Development Index (HDI) 
and its details (Gross national income (GNI) per capita, average years of 
schooling and life expectancy at birth) with age-standardized incidence rate 
(ASIR) and age-standardized mortality rate (ASMR) of PC. Results: In total, 
337872 new cases of PC occurred in 2012 around the world , that 178116 and 
159711 cases take happen in men and women respectively, also at the same 
year 330391 deaths of PC occurred ,that 173,827 and 156564 cases were in 
men and women. In assessment the relationship between HDI and ASIR and 
ASMR of PC there is significant positive correlation equal to 0.767 (p <0.001) 
between HDI and ASIR of PC, and a significant positive correlation equal to 
0.776 (p <0.001) between HDI and ASMR of PC.  
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Conclusion: The incidence and mortality of PC has a significant positive 
correlation with the Human Development Index. 
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Introduction  
Gastrointestinal cancers have high incidence and mortality rate worldwide (Jemal 
et al., 2010a; Siegel et al., 2012). pancreatic cancer (PC) is one of the cancers 
that is identified as the twelfth common cancer and the seventh death cause due 
to cancer worldwide so that its incidence was 12.2 and death due to that was 
10.9 per hundred thousand people in 2014 (Howlader et al., 2011). The highest 
incidence of PC is observed in Northern Europe and America and the lowest 
incidence is seen in African countries (Altekruse et al., 2010; Curado et al., 2007; 
Malvezzi et al., 2013; Pakzad et al., 2016). Totally, 2/3 of PC death cases occur in 
world developed countries (Parkin et al., 2005). Therefore it's known as the fifth 
deadly cancer in developed countries in 2000 (Schwartz and Reis, 2000). 
Despite the diagnosis of more than 400000 PC new cases in year, it is about 30 
years that its 5-year survival remains low and less than 4 percent is reported for 
this cancer (Baxter et al., 2007; Jemal et al., 2010b; Stats, 2012). The global 
burden of PC is increasing due to aging, population growth and high-risk 
behaviors especially smoking and world developed countries allocated the 
greatest burden of the disease (Jemal et al., 2011). As the country is more 
advanced and has higher-income, non-communicable diseases such as cancers 
include more death causes (Mathers et al., 2005). However, the cause of 
incidence and prevalence of PC is due to its risk factors including age over 70, 
smoking, race, obesity, alcohol, red and processed meat consumption, chronic 
pancreatitis, diabetes and chronic infections (hepatitis B, hepatitis C, 
Helicobacter pylori) different distribution that is believed to be higher in 
developed countries (Keane et al., 2014; Lowenfels and Maisonneuve, 2006; 
Society, 2013). The society health is the outcome of several complex, different 
and constantly changing factors (Organization, 2000). So, it should be cared, 
intervened and managed and be in the place of social and economic 
development level, continuously (Organization, 2000). Therefore, one of the 
good public health and its related factors indicator is the Human Development 
Index (HDI) (Bray et al., 2012). This index is a useful classification for cancer 
globalization (Bray et al., 2012). The HDI was determined as a comparing index 
for countries in 3 fields of human dimension by the UNDP (United Nations 
Development Program) in 1990 (Ravallion, 1997).	 Three dimensions of HDI 
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include long and healthy life, access to knowledge and good living standards 
(Bray et al., 2012). Each of these factors are measured by life expectancy at birth, 
education and GDP per capita, respectively (Bray et al., 2012).  
An estimated 5-year incidence of all cancers according to HDI regions showed 
that areas with high and very high HDI, have allocated highest prevalence of 
21.31% to themselves despite having only 6.1% of the world's population and 
this ratio was 9.237% and 1.993 % for medium and low HDI regions, respectively 
(Bray et al., 2013). 
PC among other cancers has different incidence and mortality that varies around 
the world and it is due to development and the diagnostic and therapeutic 
status of countries (Bray, 2014; Forman et al., 2014; Franceschi and Wild, 2013; 
Kanavos, 2006). 
However, a comprehensive study that could examine the association between 
HDI and age-standardized incidence rate (ASIR) and age-standardized mortality 
rate (ASMR) of PC has not been conducted. Because of this point that 
knowledge about the ASIR and ASMR of cancers and the potential role of 
development is useful in health planning, this study conducted with the purpose 
of determining the ASIR and ASMR of PC and its correlation with the HDI in the 
world in 2012.  
Materials-Methods 
This study was an ecologic study in the World for assessing the correlation 
between HDI and its details (Gross national income (GNI) per capita,	 average 
years of schooling and life expectancy at birth) with age-standardized incidence 
rate (ASIR) and age-standardized mortality rate (ASMR) of PC. Detailed 
descriptions of the methods used in	collection of data about cancer incidence 
and mortality  in GLOBOCAN (Ferlay J et al., 2016),  and HDI (Malik, 2013), and 
Statistical analysis of this study have been provided in previous reports 
(Arabsalmani et al., 2017; Ghoncheh et al., 2016; Hassanipour-Azgomi et al., 
2016; Mohammadian et al., 2017; Mohammadian et al., 2016; Rafiemanesh et 
al., 2016; Razi et al., 2016; Shuja et al., 2017; Tiyuri et al., 2017). 
Results  
The frequency of incidence of PC 
In total, 337872 PC cases have been occurred worldwide in 2012 that 178161 
and 159711 cases were in men and women	respectively (Sex Ratio = 1.11). From 
all occurred cases, about 174344 cases were in countries with very high HDI, 
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55638 cases were in countries with high HDI, 98632 cases were in countries with 
medium HDI, and 9108 cases occurred in countries with low HDI. Five countries 
with the heights sum of PC include: China (65727), America ( 42885),Japan 
(32899), Germany (16451) and Russia (14512). five countries with highest sum of 
PC case  in men include: China (39299), America (21713), Japan (17013), 
Germany (7972) and Russia (7206), and in women include: China (26428), 
America (21172), Japan (15886), Germany (8479), and Russia (7306). 
The ASIR of PC 
The ASIR of PC per hundred thousand people in the world was 4.2 (in men 4.9 
and in women 3.6). The ASIR of PC in very high HDI regions was 7.2,	in high HDI	
regions was 4.6,	in medium HDI	regions was 2.7, and	in low HDI	regions was 1.2. 
Five countries with the highest ASIR of PC are: Czech Republic (9.7), Slovakia 
(9.4), Armenia (9.3), Hungary (9.3), and Slovenia (8.8), respectively. 5 countries 
with the highest ASIR of PC for men were: Armenia (11.9), Czech Republic (11.9), 
Slovakia (11.5), Hungary (11.5), and FYR Macedonia (11.5), and in women 
include: Czech Republic (7.9), Slovenia (7.8), Slovakia (7.8), Denmark (7.7), and 
Finland (7.6). 
The frequency of mortality of PC 
Nowadays, 330391 deaths happened because of PC around the world in 2012 
that about 173827 cases were men and 156564 cases were women (Sex Ratio = 
1.11). Total number of mortality from PC was 170497	 cases in very high HDI 
region, 56474 cases in high HDI	 region, 94447 cases medium HDI region, and 
8822 cases in low HDI	 region. Five countries having the highest ASMR of PC 
were: China (63662), America (41509), Japan (31046), Russia (16371), and 
Germany (16188). Five countries having the highest ASMR of PC in men were: 
China (37775) cases, America (21005), Japan (15809), Russia (8168), and 
Germany (7900), and in women include: China (25887), America (20504), Japan 
(15237), Germany (8288), and Russia (8203).  
The ASMR of PC 
The ASMR of PC per hundred thousand people in the world was 4 (in men 4.7 
and in women 3.4). The ASMR of PC very high HDI	regions was 6.8, in high HDI	
regions was 4.6, in countries with medium HDI	 regions was 2.6,	 in low HDI	
regions was 1.2. Five countries having the highest ASMR of PC	 per hundred 
thousand people were: Armenia (8.9), Hungary (8.8), Czech Republic (8.7), 
Slovakia (8.5), and French Guiana (8.1). Five  countries having the highest ASMR 
of PC in men were: YR Macedonia (11.8), Armenia (11.6), Hungary (11.1), Estonia 
(10.6), and Latvia (10.4), and in women include: Slovakia (7.6), Czech Republic 
(7.2), Slovenia (7.2), Hungary (7), and French Guiana (7). 
The association between the ASIR of PC and the HDI 
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In assessment the relationship between ASIR of PC and the HDI,	 a	 significant 
positive correlation equal to 0.767 (p <0.001) was observed. There were positive 
correlation between	ASIR of PC and components of the HDI (with the level of 
income equal to 0.517 (p<0.001), with average years of education equal to 
0.762 (p<0.001) and with life expectancy at birth equal to 0.657 (p <0.001) (Fig. 
1).  








The association between the ASMR of PC and the HDI 
In topic of the relationship between ASMR of PC and the HDI, a significant 
positive correlation equivalent to 0.776 (p <0.001) was observed. There were 
positive correlation between ASMR of PC and components of the HDI (with the 
level of income equal to 0.518 (p<0.001), with average years of education equal 
to 0.769 (p<0.001) and with life expectancy at birth equal to 0.666 (p <0.001) 
(Fig. 2).  
Figure 2. The 
relationship between 
standardized mortality 
rate and the Human 
Development Index.  
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Discussion 
PC has allocated the mortality rate of 39.4 and incidence rate of 54.9 cases per 
100,000 people of the population to itself in 2008 (Hu et al., 2013). Also, 
according to a cohort study that has been conducted in 2000-2010, incidence of 
PC has increased 3% annually (Keane et al., 2014).  
In this study, ASIR of PC was estimated 4.2 per hundred thousand people in the 
world and has a positive correlation of 0.767 with the HDI that this association is 
statistically significant. Czech Republic, Slovakia, Armenia, Hungary and Slovenia 
were 5 countries that allocated the highest rate of incidence to them. This is in 
condition that every five country is located in group of countries with high and 
very high HDI.  
According to studies, the incidence of PC in industrial developed countries is 
more than developing ones. In a systematic study which Rio conducted in 
1975-2007, it's estimated that the highest incidence of PC belongs to Northern 
Europe and America (Altekruse et al., 2010). Estimating incidence age specified 
rates (ASRs) is 10.1 for both sexes per hundred thousand people based on 
gender in Europe in 2012 (Ferlay et al., 2013). While, the same rate is estimated 
to be 3.2 per hundred thousand people in Asia in 2012 (Pourhoseingholi et al., 
2014). 
The diseases incidence is associated with their risk factors (Ward et al., 2004). 
Age and smoking are strong factors that always are reported (Bonelli et al., 
2003; Fuchs et al., 1996; Hassan et al., 2007; Hippisley-Cox and Coupland, 
2012; Larsson et al., 2005; Muscat et al., 1997; Silverman et al., 1994; Stapley et 
al., 2012; Valean et al., 2015). So that by increasing the number of years of life 
that passes by smoking cigarettes, the risk to catch PC also boost per person 
(Keyghobadi et al., 2015). Variety diet could be mentioned that other risk 
factors. Also several studies have shown that the total amount of calorie and 
probably fat increase in the diet and obesity, may arise the risk of PC (Ghadirian 
et al., 1990). Finally, we can say that the high level of these factors in developed 
countries has led to a greater incidence of PC.  
The ASMR of PC was 4 per hundred thousand people in the world in this study 
and a positive correlation of 0.776 was seen between ASMR of PC and the HDI 
that this was statistically significant. 5 countries having the highest ASMR of PC 
are: Armenia, Hungary, Czech Republic, Slovakia, and French Guiana. So that 
Armenia and French Guiana are located in group of countries with high HDI and 
three other ones in countries with very high HDI. 
Also, due to the results of studies that have been conducted between the years 
1993-95, it's estimated that PC was the sixth cause of death among cancers in 
the United States of America and the United Kingdom (Berman, 1995; Gold and 
Goldin, 1998). Also in 2002, according to cancer mortality in the world, the 
incidence of PC is estimated to be 6-8 per 100 thousand people in men and 4-6 
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per 100 thousand people in women in developed countries such as Australia 
and Japan (Parkin et al., 2005).   
In many Asian countries such as Korea, Singapore and China that have a high 
HDI, PC mortality is high too (Parkin et al., 2005; Wang et al., 2003).  
In this study, the incidence in men is 4.9 and in women is 3.6 per hundred 
thousand people and the mortality is 4.7 for men and 3.4 per hundred thousand 
in women. 
However, in all cancer centers an association is reported between PC and 
gender (Bramhall et al., 1995). The prevalence of this disease in men is more 
than women (Bramhall et al., 1995). So that due to global estimation in 2012, the 
rate of mortality to incidence of cancer in both sexes is almost close (0.94 / 0.97)
(Valean et al., 2015). Although the incidence in men is generally a little more 
than women, the high incidence and mortality of PC in men has a variety of 
causes such as increase in smoking (Muniraj et al., 2013), diet (high fat and 
protein, low fruit and vegetable consumption), consumption of coffee, alcohol 
and Job hazards (insecticides, aluminum, nickel and acrylamide) that these 
things cases are seen more in men's lifestyle (Greene et al., 2008; Lowenfels et 
al., 1997). While, elevated estrogen in women acts as a death cause lowering 
agent of PC (Greene et al., 2008).  
In this study, a positive correlation was observed between the ASIR and ASMR of 
PC and life expectancy at birth. Also it has been seen in several studies that with 
increasing age, the incidence of PC dramatically raised up increases (Ferlay et 
al., 2015; Hartwig et al., 2009; Neesse et al., 2010; Sasson et al., 2002; Toriola et 
al., 2014). So that the cause for increasing incidence of this cancer in developed 
countries, may be a reflection of aging (Pakzad et al., 2015c; Smith et al., 2009). 
In this study, a significant positive correlation was seen between the ASIR and 
ASMR of PC with mean education level. Also in Bosetti et al study, the incidence 
is increased with increasing level of education (Bosetti et al., 2012). Also about 
the PC mortality, the mortality is increased in less educated individuals with age 
under 15 years (Jemal et al., 2013). 
In this study, a significant positive correlation was seen between the ASIR and 
ASMR of PC with average income level. According to several studies, patients 
with high socio-economic status and PC have good chance for surgical 
treatment but has no significant impact on patient survival (Bakens et al., 2015; 
Michaud, 2004; Pakzad et al., 2015a, b). Surgery as the only treatment option for 
long-term survival in patients with PC as an indicator of the impact of social and 
economic inequality, is a good witness that socioeconomic status has the lowest 
effect on patient's survival (Bakens et al., 2015; Michaud, 2004). Because the 
average survival of PC is 3-6 months since diagnosis without treatment that has 
up to 23 months increase after surgery and adjunctive therapies (Neoptolemos 
et al., 2001; Neoptolemos et al., 2010). That's why we can say that the incidence 
of PC is near to its mortality rate (Michaud, 2004; Ryu et al., 2010). Although in 
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several studies observed that patients with higher income have more 
improvement than others, but this improvement is very low. Therefore, we 
cannot consider its protective effects very important (Neoptolemos et al., 2001; 
Neoptolemos et al., 2010).  
Conclusion 
We can say that, the incidence and mortality of PC has a significant positive 
correlation with the Human Development Index and its components.   
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